$709 Million is the total value of Meditor Group Ltd's 36 reported holdings in Q3 2013. The portfolio turnover from Q2 2013 to Q3 2013 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| EXEL | EXELIXIS INC | $69,840,000 | +28.2% | 12,000,000 | 0.0% | 9.85% | +33.5% | |
| VVUS | VIVUS INC | $39,128,000 | -26.1% | 4,207,296 | 0.0% | 5.52% | -23.0% | |
| NYX | NYSE EURONEXT | $32,579,000 | +1.4% | 776,070 | 0.0% | 4.59% | +5.6% | |
| NKTR | NEKTAR THERAPEUTICS | $15,145,000 | -9.6% | 1,450,000 | 0.0% | 2.14% | -5.8% | |
| WCRX | WARNER CHILCOTT PLC-CLASS A | $12,978,000 | +15.2% | 566,000 | 0.0% | 1.83% | +19.9% | |
| LBTYK | LIBERTY GLOBAL PLC-SERIES Ccl c | $12,767,000 | +11.1% | 169,254 | 0.0% | 1.80% | +15.7% | |
| SHPG | SHIRE PLC-ADRadr | $8,392,000 | +26.0% | 70,000 | 0.0% | 1.18% | +31.2% | |
| APC | ANADARKO PETROLEUM CORP | $3,906,000 | +8.2% | 42,000 | 0.0% | 0.55% | +12.7% | |
| VALE | VALE SA-SP ADRadr | $3,425,000 | +18.7% | 219,400 | 0.0% | 0.48% | +23.5% | |
| BAC | BANK OF AMERICA CORP | $3,367,000 | +7.3% | 244,000 | 0.0% | 0.48% | +11.8% | |
| DAL | DELTA AIR LINES INC | $2,925,000 | +26.1% | 124,000 | 0.0% | 0.41% | +31.2% | |
| CCL | CARNIVAL CORPctf | $1,488,000 | -4.9% | 45,600 | 0.0% | 0.21% | -0.9% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2013-10-25
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| EXELIXIS INC | 43 | Q4 2023 | 88.9% |
| ALKERMES PLC | 31 | Q4 2020 | 62.6% |
| ISHARES MSCI INDIA ETF | 31 | Q4 2023 | 5.5% |
| WISDOMTREE INDIA EARNINGS FUND | 31 | Q4 2023 | 5.5% |
| ESPERION THERAPEUTICS INC | 27 | Q4 2023 | 34.4% |
| VIVUS INC | 15 | Q4 2016 | 21.3% |
| CELLDEX THERAPEUTICS | 14 | Q2 2020 | 2.7% |
| PROSHARES ULTRAPRO SHORT S&P500 | 4 | Q4 2017 | 3.8% |
| PROSHARES ULTRASHORT S&P500 | 4 | Q4 2017 | 3.0% |
| PROSHARES ULTRASHORT S&P 500 ETF | 3 | Q3 2019 | 0.8% |
View Meditor Group Ltd's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| EXELIXIS, INC. | April 09, 2019 | 15,001,073 | 5.0% |
| VIVUS INC | December 19, 2012 | 5,002,896 | 5.0% |
| VIVUS INC | March 21, 2012 | 6,177,500 | 6.3% |
| VION PHARMACEUTICALS INC | February 15, 2008 | 5,736,200 | 7.6% |
| CYPRESS BIOSCIENCE INC | September 26, 2007 | 1,864,645 | 5.0% |
| ONYX PHARMACEUTICALS INC | September 12, 2007 | 2,627,800 | 4.8% |
| ACUSPHERE INC | July 26, 2007 | 1,839,421 | 4.0% |
| NOVACEA INC | June 11, 2007 | 800,000 | 3.4% |
| ATHEROGENICS INC | May 02, 2007 | 1,361,800 | 3.5% |
View Meditor Group Ltd's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-11 |
| 13F-HR | 2024-01-04 |
| SC 13G/A | 2024-01-03 |
| 13F-HR | 2023-10-31 |
| 13F-HR | 2023-07-25 |
| 13F-HR | 2023-04-10 |
| 13F-HR | 2023-01-05 |
| SC 13G/A | 2023-01-04 |
| 13F-HR | 2022-11-07 |
| 13F-HR | 2022-07-18 |
View Meditor Group Ltd's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.